Milestone Pharmaceuticals MIST Q1 2026 Earnings Significant EPS Miss as PreRevenue Biotech Continues Pipeline Development VLYPO Q1 2026 Earnings Slight EPS Beat Amid Stable Operations XOMAP Q1 2026 Earnings EPS Misses Estimates Amid Ongoing Royalty Fluctuations OMCL Q1 2026 Earnings Stellar EPS Beat of 6277 Yet Stock Slides NCMI Q1 2026 Earnings EPS Miss Exceeds Estimates Stock Edges Higher AU Q1 2026 Earnings EPS Beats Estimates by 806 Stock Rises 756